Cargando…

Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma

BACKGROUND: The aim of this study was to construct a model based on the prognostic features associated with epithelial–mesenchymal transition (EMT) to explore the various mechanisms and therapeutic strategies available for the treatment of metastasis and invasion by hepatocellular carcinoma (HCC) ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Dafeng, Wang, Yu, Wu, Jincai, Lin, Shixun, Chen, Yonghai, Zheng, Jinfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613962/ https://www.ncbi.nlm.nih.gov/pubmed/34819088 http://dx.doi.org/10.1186/s12935-021-02326-8

Ejemplares similares

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Development and Validation of a Novel 8 Immune Gene Prognostic Signature Based on the Immune Expression Profile for Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2020)

Systematic Analysis of an Invasion-Related 3-Gene Signature and Its Validation as a Prognostic Model for Pancreatic Cancer
por: Xu, Dafeng, et al.
Publicado: (2021)

ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway
por: Xu, Dafeng, et al.
Publicado: (2021)

Correction to: ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2/PLK1/PTEN pathway
por: Xu, Dafeng, et al.
Publicado: (2022)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Piezo1 promoted hepatocellular carcinoma progression and EMT through activating TGF-β signaling by recruiting Rab5c
por: Li, Yi-ming, et al.
Publicado: (2022)

Identification and integrative analysis of ACLY and related gene panels associated with immune microenvironment reveal prognostic significance in hepatocellular carcinoma
por: Xu, Yunfeng, et al.
Publicado: (2021)

Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma
por: Qin, Rujia, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients
por: Qiu, Jieping, et al.
Publicado: (2020)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma
por: Xu, Guili, et al.
Publicado: (2021)

Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma
por: Liu, Xin-rui, et al.
Publicado: (2016)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma
por: Lin, Zhen, et al.
Publicado: (2021)

Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance
por: Jin, Pei-Ying, et al.
Publicado: (2019)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Construction of a single nucleotide variant score-related gene-based prognostic model in hepatocellular carcinoma: analysis of multi-independent databases and validation in vitro
por: Xu, Yu-Jie, et al.
Publicado: (2021)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2020)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis
por: Cui, Jie, et al.
Publicado: (2020)

CTCF-silenced miR-137 contributes to EMT and radioresistance in esophageal squamous cell carcinoma
por: Xu, Shuwen, et al.
Publicado: (2021)

M2 macrophages secrete CXCL13 to promote renal cell carcinoma migration, invasion, and EMT
por: Xie, Yingwei, et al.
Publicado: (2021)

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Identification and validation of a pyroptosis-related prognostic signature for thyroid cancer
por: Wu, Pu, et al.
Publicado: (2021)

Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis
por: Luo, Yangkun, et al.
Publicado: (2016)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

Identification and validation of a hypoxia-related prognostic and immune microenvironment signature in bladder cancer
por: Sun, Xianchao, et al.
Publicado: (2021)

Identification and validation of m(6)A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer
por: Wang, Xinyi, et al.
Publicado: (2020)

Identification and validation of cellular senescence patterns to predict clinical outcomes and immunotherapeutic responses in lung adenocarcinoma
por: Lin, Weihao, et al.
Publicado: (2021)

Expression of B7-H6 expression in human hepatocellular carcinoma and its clinical significance
por: Chen, Lujun, et al.
Publicado: (2018)

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma
por: Pang, Yilin, et al.
Publicado: (2021)

Identification of glycolysis related pathways in pancreatic adenocarcinoma and liver hepatocellular carcinoma based on TCGA and GEO datasets
por: Li, Ji, et al.
Publicado: (2021)

Prognostic value of preoperative inflammatory markers in patients with hepatocellular carcinoma who underwent curative resection
por: Wu, Wenlong, et al.
Publicado: (2021)

The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer
por: Melissaridou, Styliani, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_59c373pqg54pt645d97c5m59n4